Hugo Harrod on How MVM’s Investment Strategy Shaped Its 2024 Medtech Exits
Harrod discusses how MVM built a successful medtech investment strategy and its rationale for investing in Vertos Medical and Gynesonics, two successful exits this year, demonstrating MVM’s optimism about medtech investing overall.
Read Article